One-step real-time PCR assay for detection and quantification of RNA HCV to monitor patients under treatment in Brazil

ABSTRACT The Brazilian Public Health Service provides freely αPEG-IFN to treat patients infected with HCV. The primary goal of HCV therapy is the long-term elimination of HCV from the blood to reduce the risk of HCV associated complications and death. Patient viremia affects the treatment duration and response, thus influencing clinical decisions. We developed a high-throughput method to perform the quantification of RNA hepatitis C virus (HCV) virus load in plasma samples to monitor patients under treatment. The method is based on a duplex detection, in a one-step real-time RT-PCR assay and it has been validated according to the rules established by the official Brazilian regulatory agency (ANVISA). This new method was compared to a commercial kit (Cobas/Taqman HCV Test v2.0 - Roche), showing virus load results with significant correlation between them (p= 0,012) using commercial and clinical panels. In addition, 611 samples from patients treated with peguilated alfa-interferon (αPEG-IFN) from different regions of Brazil were analyzed. Our one-step real-time RT-PCR assay demonstrated good performance in viral load measurement and in treatment course monitoring, with acceptable sensitivity and specificity values.

Saved in:
Bibliographic Details
Main Authors: Andrade,Elisabete, Rocha,Daniele, Fontana-Maurell,Marcela, Costa,Elaine, Ribeiro,Marisa, de Godoy,Daniela Tupy, Ferreira,Antonio G.P., Tanuri,Amilcar, Alvarez,Patrícia, Brindeiro,Rodrigo
Format: Digital revista
Language:English
Published: Brazilian Society of Infectious Diseases 2018
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702018000500418
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1413-86702018000500418
record_format ojs
spelling oai:scielo:S1413-867020180005004182018-12-14One-step real-time PCR assay for detection and quantification of RNA HCV to monitor patients under treatment in BrazilAndrade,ElisabeteRocha,DanieleFontana-Maurell,MarcelaCosta,ElaineRibeiro,Marisade Godoy,Daniela TupyFerreira,Antonio G.P.Tanuri,AmilcarAlvarez,PatríciaBrindeiro,Rodrigo HCV viral load Real Time PCR monitoring patients ABSTRACT The Brazilian Public Health Service provides freely αPEG-IFN to treat patients infected with HCV. The primary goal of HCV therapy is the long-term elimination of HCV from the blood to reduce the risk of HCV associated complications and death. Patient viremia affects the treatment duration and response, thus influencing clinical decisions. We developed a high-throughput method to perform the quantification of RNA hepatitis C virus (HCV) virus load in plasma samples to monitor patients under treatment. The method is based on a duplex detection, in a one-step real-time RT-PCR assay and it has been validated according to the rules established by the official Brazilian regulatory agency (ANVISA). This new method was compared to a commercial kit (Cobas/Taqman HCV Test v2.0 - Roche), showing virus load results with significant correlation between them (p= 0,012) using commercial and clinical panels. In addition, 611 samples from patients treated with peguilated alfa-interferon (αPEG-IFN) from different regions of Brazil were analyzed. Our one-step real-time RT-PCR assay demonstrated good performance in viral load measurement and in treatment course monitoring, with acceptable sensitivity and specificity values.info:eu-repo/semantics/openAccessBrazilian Society of Infectious DiseasesBrazilian Journal of Infectious Diseases v.22 n.5 20182018-10-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702018000500418en10.1016/j.bjid.2018.08.003
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Andrade,Elisabete
Rocha,Daniele
Fontana-Maurell,Marcela
Costa,Elaine
Ribeiro,Marisa
de Godoy,Daniela Tupy
Ferreira,Antonio G.P.
Tanuri,Amilcar
Alvarez,Patrícia
Brindeiro,Rodrigo
spellingShingle Andrade,Elisabete
Rocha,Daniele
Fontana-Maurell,Marcela
Costa,Elaine
Ribeiro,Marisa
de Godoy,Daniela Tupy
Ferreira,Antonio G.P.
Tanuri,Amilcar
Alvarez,Patrícia
Brindeiro,Rodrigo
One-step real-time PCR assay for detection and quantification of RNA HCV to monitor patients under treatment in Brazil
author_facet Andrade,Elisabete
Rocha,Daniele
Fontana-Maurell,Marcela
Costa,Elaine
Ribeiro,Marisa
de Godoy,Daniela Tupy
Ferreira,Antonio G.P.
Tanuri,Amilcar
Alvarez,Patrícia
Brindeiro,Rodrigo
author_sort Andrade,Elisabete
title One-step real-time PCR assay for detection and quantification of RNA HCV to monitor patients under treatment in Brazil
title_short One-step real-time PCR assay for detection and quantification of RNA HCV to monitor patients under treatment in Brazil
title_full One-step real-time PCR assay for detection and quantification of RNA HCV to monitor patients under treatment in Brazil
title_fullStr One-step real-time PCR assay for detection and quantification of RNA HCV to monitor patients under treatment in Brazil
title_full_unstemmed One-step real-time PCR assay for detection and quantification of RNA HCV to monitor patients under treatment in Brazil
title_sort one-step real-time pcr assay for detection and quantification of rna hcv to monitor patients under treatment in brazil
description ABSTRACT The Brazilian Public Health Service provides freely αPEG-IFN to treat patients infected with HCV. The primary goal of HCV therapy is the long-term elimination of HCV from the blood to reduce the risk of HCV associated complications and death. Patient viremia affects the treatment duration and response, thus influencing clinical decisions. We developed a high-throughput method to perform the quantification of RNA hepatitis C virus (HCV) virus load in plasma samples to monitor patients under treatment. The method is based on a duplex detection, in a one-step real-time RT-PCR assay and it has been validated according to the rules established by the official Brazilian regulatory agency (ANVISA). This new method was compared to a commercial kit (Cobas/Taqman HCV Test v2.0 - Roche), showing virus load results with significant correlation between them (p= 0,012) using commercial and clinical panels. In addition, 611 samples from patients treated with peguilated alfa-interferon (αPEG-IFN) from different regions of Brazil were analyzed. Our one-step real-time RT-PCR assay demonstrated good performance in viral load measurement and in treatment course monitoring, with acceptable sensitivity and specificity values.
publisher Brazilian Society of Infectious Diseases
publishDate 2018
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702018000500418
work_keys_str_mv AT andradeelisabete onesteprealtimepcrassayfordetectionandquantificationofrnahcvtomonitorpatientsundertreatmentinbrazil
AT rochadaniele onesteprealtimepcrassayfordetectionandquantificationofrnahcvtomonitorpatientsundertreatmentinbrazil
AT fontanamaurellmarcela onesteprealtimepcrassayfordetectionandquantificationofrnahcvtomonitorpatientsundertreatmentinbrazil
AT costaelaine onesteprealtimepcrassayfordetectionandquantificationofrnahcvtomonitorpatientsundertreatmentinbrazil
AT ribeiromarisa onesteprealtimepcrassayfordetectionandquantificationofrnahcvtomonitorpatientsundertreatmentinbrazil
AT degodoydanielatupy onesteprealtimepcrassayfordetectionandquantificationofrnahcvtomonitorpatientsundertreatmentinbrazil
AT ferreiraantoniogp onesteprealtimepcrassayfordetectionandquantificationofrnahcvtomonitorpatientsundertreatmentinbrazil
AT tanuriamilcar onesteprealtimepcrassayfordetectionandquantificationofrnahcvtomonitorpatientsundertreatmentinbrazil
AT alvarezpatricia onesteprealtimepcrassayfordetectionandquantificationofrnahcvtomonitorpatientsundertreatmentinbrazil
AT brindeirorodrigo onesteprealtimepcrassayfordetectionandquantificationofrnahcvtomonitorpatientsundertreatmentinbrazil
_version_ 1756416561125523456